Last Updated : May 2, 2025
Details
| Call for patient/clinician input open | 26-Mar-24 |
|---|---|
| Call for patient/clinician input closed | 21-May-24 |
| Submission received | 08-May-24 |
| Submission accepted | 23-May-24 |
| Review initiated | 24-May-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 23-Aug-24 |
| Deadline for sponsors comments | 04-Sep-24 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 26-Sep-24 |
| Expert committee meeting (initial) | 09-Oct-24 |
| Draft recommendation issued to sponsor | 24-Oct-24 |
| Draft recommendation posted for stakeholder feedback | 31-Oct-24 |
| End of feedback period | 15-Nov-24 |
| Final recommendation issued to sponsor and drug plans | 27-Nov-24 |
| Final recommendation posted | 13-Dec-24 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 11-Dec-24 |
| CDA-AMC review report(s) posted | 02-Apr-25 |